Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study
(Q46414306)
scientific article published in August 2008
scientific article published in August 2008
Language:
other details
| description | scientific article published in August 2008 |
External Links
| (P356) |
10.1016/S0140-6736(08)61081-8
|
| (P698) |
18722869
|